HERSHBERG ROBERT bought RXRX
October 6, 2026 · Form 4 insider transaction
HERSHBERG ROBERT bought 25,000 shares of Recursion Pharmaceuticals, Inc. at $2.22 per share, a transaction worth $55.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$2.22
Total value
$55.5K
InsiderHERSHBERG ROBERT
RoleOfficer, Director
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateOctober 6, 2026
Filing dateOctober 7, 2026
Shares owned after187,156
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025.